Current perspectives of the signaling pathways directing neural crest induction

por Stuhlmiller, Timothy J., García-Castro, Martín I.
Publicado 2012

Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies

por Joisa, Chinmaya U., Chen, Kevin A., Beville, Samantha, Stuhlmiller, Timothy, Berginski, Matthew E., Okumu, Denis, Golitz, Brian T., Johnson, Gary L., Gomez, Shawn M.
Publicado 2023

Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Tr...

por Stuhlmiller, Timothy J., Zawistowski, Jon S., Chen, Xin, Sciaky, Noah, Angus, Steven P., Hicks, Sean T., Parry, Traci L., Huang, Wei, Beak, Ju Youn, Willis, Monte S., Johnson, Gary L., Jensen, Brian C.
Publicado 2017

Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma

por Wolfe, Zachary, Friedland, Julie C., Ginn, Sarah, Blackham, Aaron, Demberger, Lauren, Horton, Morgan, McIntosh, Alyson, Sheikh, Hina, Box, Jessica, Knoerzer, Deborah, Federowicz, Bryan, Stuhlmiller, Timothy J., Shapiro, Mark, Nair, Suresh
Publicado 2022

Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer

por Collins, Kyla A.L., Stuhlmiller, Timothy J., Zawistowski, Jon S., East, Michael P., Pham, Trang T., Hall, Claire R., Goulet, Daniel R., Bevill, Samantha M., Angus, Steven P., Velarde, Sara H., Sciaky, Noah, Oprea, Tudor I., Graves, Lee M., Johnson, Gary L., Gomez, Shawn M.
Publicado 2018

Limited inhibition of multiple nodes in a driver network blocks metastasis

por Yesilkanal, Ali Ekrem, Yang, Dongbo, Valdespino, Andrea, Tiwari, Payal, Sabino, Alan U, Nguyen, Long Chi, Lee, Jiyoung, Xie, Xiao-He, Sun, Siqi, Dann, Christopher, Robinson-Mailman, Lydia, Steinberg, Ethan, Stuhlmiller, Timothy, Frankenberger, Casey, Goldsmith, Elizabeth, Johnson, Gary L, Ramos, Alexandre F, Rosner, Marsha R
Publicado 2021

High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy

por Cheng, Chialin, Reis, Surya A., Adams, Emily T., Fass, Daniel M., Angus, Steven P., Stuhlmiller, Timothy J., Richardson, Jared, Olafson, Hailey, Wang, Eric T., Patnaik, Debasis, Beauchamp, Roberta L., Feldman, Danielle A., Silva, M. Catarina, Sur, Mriganka, Johnson, Gary L., Ramesh, Vijaya, Miller, Bruce L., Temple, Sally, Kosik, Kenneth S., Dickerson, Bradford C., Haggarty, Stephen J.
Publicado 2021

FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036

por Angus, Steven P., Stuhlmiller, Timothy J., Mehta, Gaurav, Bevill, Samantha M., Goulet, Daniel R., Olivares-Quintero, J. Felix, East, Michael P., Tanioka, Maki, Zawistowski, Jon S., Singh, Darshan, Sciaky, Noah, Chen, Xin, He, Xiaping, Rashid, Naim U., Chollet-Hinton, Lynn, Fan, Cheng, Soloway, Matthew G., Spears, Patricia A., Jefferys, Stuart, Parker, Joel S., Gallagher, Kristalyn K., Forero-Torres, Andres, Krop, Ian E., Thompson, Alastair M., Murthy, Rashmi, Gatza, Michael L., Perou, Charles M., Earp, H. Shelton, Carey, Lisa A., Johnson, Gary L.
Publicado 2021